The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo.
Open accessAbstract
We have explored the use of primary myoblasts as a somatic tissue for gene therapy of acquired and inherited diseases where systemic delivery of a gene product may have therapeutic effects. Mouse primary myoblasts were infected with replication-defective retroviruses expressing canine factor IX cDNA under the control of a mouse muscle creatine kinase enhancer and human cytomegalovirus promoter. The infected myoblasts were injected into the hindlegs of recipient mice and levels of secreted factor IX protein were monitored in the plasma. We report sustained expression of factor IX protein for over 6 months without any apparent adverse effect on the recipient mice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional messenger RNAs are produced by SP6 in vitro transcription of cloned cDNAs
Krieg, P. A., & Melton, D. A. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.18.7057 · Cited by 1,533
Cationic liposome-mediated RNA transfection.
Malone, R. W., Felgner, P. L., & Verma, I. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.16.6077 · Cited by 911
Self-citationHuman gene therapy comes of age
Miller, A. D. (1992) · Nature · doi:10.1038/357455a0 · Cited by 908
Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts
Partridge, T. A., Morgan, J. E., Coulton, G. R., Hoffman, E. P., & Kunkel, L. M. (1989) · Nature · doi:10.1038/337176a0 · Cited by 878
Construction and use of a safe and efficient amphotropic packaging cell line
MARKOWITZ, D., GOFF, S., & BANK, A. (1988) · Virology · doi:10.1016/s0042-6822(88)90101-8 · Cited by 670
Progress Toward Human Gene Therapy
Friedmann, T. (1989) · Science · doi:10.1126/science.2660259 · Cited by 480
Palmer, T. D., Rosman, G. J., Osborne, W. R., & Miller, A. D. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.4.1330 · Cited by 479
Systemic Delivery of Human Growth Hormone by Injection of Genetically Engineered Myoblasts
Dhawan, J., Pan, L. C., Pavlath, G. K., Travis, M. A., Lanctot, A. M., & Blau, H. M. (1991) · Science · doi:10.1126/science.1962213 · Cited by 317
Systemic Delivery of Recombinant Proteins by Genetically Modified Myoblasts
Barr, E., & Leiden, J. M. (1991) · Science · doi:10.1126/science.1962212 · Cited by 281
Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants.
Scharfmann, R., Axelrod, J. H., & Verma, I. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4626 · Cited by 280
Self-citation
Cited by
The Basic Science of Gene Therapy
Mulligan, R. C. (1993) · Science · doi:10.1126/science.8493530 · Cited by 1,741
Gene therapy - promises, problems and prospects
Verma, I. M., & Somia, N. (1997) · Nature · doi:10.1038/38410 · Cited by 1,681
Self-citationNaldini, L., Blömer, U., Gage, F. H., Trono, D., & Verma, I. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11382 · Cited by 1,499
Self-citationRando, T. A., & Blau, H. M. (1994) · The Journal of cell biology · doi:10.1083/jcb.125.6.1275 · Cited by 936
Xiao, X., Li, J., & Samulski, R. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.11.8098-8108.1996 · Cited by 912
Episomal Vectors Rapidly and Stably Produce High-Titer Recombinant Retrovirus
Kinsella, T. M., & Nolan, G. P. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.12-1405 · Cited by 734
VEGF Gene Delivery to Myocardium: Deleterious Effects of Unregulated Expression
Lee, R. J., Springer, M. L., Blanco-Bose, W. E., Shaw, R., Ursell, P. C., & Blau, H. M. (2000) · Circulation · doi:10.1161/01.cir.102.8.898 · Cited by 697
Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors
Kafri, T., Blömer, U., Peterson, D. A., Gage, F. H., & Verma, I. M. (1997) · Nature Genetics · doi:10.1038/ng1197-314 · Cited by 605
Self-citationDai, Y., Schwarz, E. M., Gu, D., Zhang, W. W., Sarvetnick, N., & Verma, I. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1401 · Cited by 591
Self-citationRiddell, S. R., Elliott, M., Lewinsohn, D. A., Gilbert, M. J., Wilson, L., Manley, S. A., Lupton, S. D., Overell, R. W., Reynolds, T. C., Corey, L., et al. (1996) · Nature Medicine · doi:10.1038/nm0296-216 · Cited by 565
LIEBERMAN, J. R., DALUISKI, A., STEVENSON, S., JOLLA, L., WU, L., McALLISTER, P., LEE, Y. P., KABO, J. M., FINERMAN, G. A. M., BERK, A. J., et al. (1999) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-199907000-00002 · Cited by 527
Xiang, Z., & Ertl, H. C. J. (1995) · Immunity · doi:10.1016/s1074-7613(95)80001-8 · Cited by 477
Manthorpe, M., Cornefert-Jensen, F., Hartikka, J., Felgner, J., Rundell, A., Margalith, M., & Dwarki, V. (1993) · Human Gene Therapy · doi:10.1089/hum.1993.4.4-419 · Cited by 432
Springer, M. L., Chen, A. S., Kraft, P. E., Bednarski, M., & Blau, H. M. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80154-9 · Cited by 363
Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice
Smith, T. A. G., Mehaffey, M. G., Kayda, D. B., Saunders, J. M., Yei, S., Trapnell, B. C., McClelland, A., & Kaleko, M. (1993) · Nature Genetics · doi:10.1038/ng1293-397 · Cited by 335
An Improved Plasmid DNA Expression Vector for Direct Injection into Skeletal Muscle
Hartikka, J., Sawdey, M., Cornefert-Jensen, F., Margalith, M., Barnhart, K., Nolasco, M., Vahlsing, H. L., Meek, J., Marquet, M., Hobart, P., et al. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.10-1205 · Cited by 328
Plasmid DNA Is Superior to Viral Vectors for Direct Gene Transfer into Adult Mouse Skeletal Muscle
Davis, H. L., Demeneix, B. A., Quantin, B., Coulombe, J., & Whalen, R. G. (1993) · Human Gene Therapy · doi:10.1089/hum.1993.4.6-733 · Cited by 307
Lieberman, J. R., Le, L. Q., Wu, L., Finerman, G. A. M., Berk, A., Witte, O. N., & Stevenson, S. (1998) · Journal of Orthopaedic Research · doi:10.1002/jor.1100160309 · Cited by 306
In Vivo Gene Therapy of Hemophilia B: Sustained Partial Correction in Factor IX-Deficient Dogs
Kay, M. A., Rothenberg, S., Landen, C. N., Bellinger, D. A., Leland, F., Toman, C., Finegold, M., Thompson, A. R., Read, M. S., Brinkhous, K. M., et al. (1993) · Science · doi:10.1126/science.8211118 · Cited by 304
Persistence in muscle of an adenoviral vector that lacks all viral genes
Chen, H.-H., Mack, L. M., Kelly, R., Ontell, M., Kochanek, S., & Clemens, P. R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1645 · Cited by 291
Löser, P., Jennings, G. S., Strauss, M., & Sandig, V. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.180-190.1998 · Cited by 279
Brunetti-Pierri, N., Palmer, D. J., Beaudet, A. L., Carey, K. D., Finegold, M., & Ng, P. (2004) · Human Gene Therapy · doi:10.1089/10430340460732445 · Cited by 256
Human foamy virus genome possesses an internal, Bel-1-dependent and functional promoter
Löchelt, M., Muranyi, W., & Flügel, R. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.15.7317 · Cited by 151
Zhang, Y., Chirmule, N., Gao, G.-P., & Wilson, J. (2000) · Journal of Virology · doi:10.1128/jvi.74.17.8003-8010.2000 · Cited by 119
Myoblast-mediated gene transfer to the joint
Day, C. S., Kasemkijwattana, C., Menetrey, J., Floyd, S. S., Booth, D., Moreland, M. S., Fu, F. H., & Huard, J. (1997) · Journal of Orthopaedic Research · doi:10.1002/jor.1100150616 · Cited by 66
Metadata
- Authors
- Dai, Y., Roman, M., Naviaux, R. K., & Verma, I. M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1992-11-15
- Volume
- 89
- Issue
- 22
- Pages
- 10892-10895
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2078625513
- Cited by
- 302
- References
- 22
- FWCI
- 13.95
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.